China Universal Asset Management Co., Ltd. Pep Gen Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$5.0 - $9.09 $1,520 - $2,763	304 Added 97.75%	615 $3,000
Q3 2023 Oct 30, 2023	BUY	$5.0 - $9.09 $1,520 - $2,763	304 Added 97.75%	615 $3,000
Q2 2023 May 21, 2024	SELL	$8.94 - $16.39 $80 - $147	-9 Reduced 2.81%	311 $2,000
Q2 2023 Jul 27, 2023	SELL	$8.94 - $16.39 $80 - $147	-9 Reduced 2.81%	311 $3,000
Q1 2023 May 21, 2024	BUY	$11.44 - $17.7 $915 - $1,416	80 Added 33.33%	320 $3,000
Q1 2023 Apr 27, 2023	BUY	$11.44 - $17.7 $915 - $1,416	80 Added 33.33%	320 $4,000
Q4 2022 May 21, 2024	BUY	$9.31 - $16.57 $2,234 - $3,976	240 New	240 $3,000
Q4 2022 Jan 31, 2023	BUY	$9.31 - $16.57 $2,234 - $3,976	240 New	240 $3,000

Others Institutions Holding PEPG

# of Institutions

Shares Held

25.2M

Call Options Held

Put Options Held

Ra Capital Management, L.P. Boston, MA

10.7M
Shares

$40.3 Million
1.27% of portfolio
Janus Henderson Group PLC London, X0

2.34M
Shares

$8.81 Million
0.01% of portfolio
Suvretta Capital Management, LLC New York, NY

1.66M
Shares

$6.26 Million
0.56% of portfolio
Viking Global Investors LP

1.48M
Shares

$5.59 Million
0.05% of portfolio
Perceptive Advisors LLC New York, NY

1.41M
Shares

$5.32 Million
0.32% of portfolio

View Full List

About PepGen Inc.

Ticker PEPG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,631,900
Market Cap $89.1M
Description
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...

More about PEPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account